VPS26B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.5247000000056E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.13110000000838E-05 |
Normal-vs-Stage2 |
7.675900E-02 |
Normal-vs-Stage3 |
4.832700E-04 |
Normal-vs-Stage4 |
8.02610000000259E-05 |
Stage1-vs-Stage2 |
3.377800E-01 |
Stage1-vs-Stage3 |
6.689000E-01 |
Stage1-vs-Stage4 |
1.208840E-01 |
Stage2-vs-Stage3 |
2.211200E-01 |
Stage2-vs-Stage4 |
4.402200E-02 |
Stage3-vs-Stage4 |
1.752620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.17560000000239E-05 |
Normal-vs-AfricanAmerican |
1.679880E-02 |
Normal-vs-Asian |
3.117400E-01 |
Caucasian-vs-AfricanAmerican |
9.628000E-02 |
Caucasian-vs-Asian |
9.854200E-01 |
AfricanAmerican-vs-Asian |
6.424400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.1776000003193E-07 |
Normal-vs-Female |
5.319800E-01 |
Male-vs-Female |
2.17129999999788E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.016800E-03 |
Normal-vs-Extreme_Weight |
4.96289999984967E-07 |
Normal-vs-Obese |
1.267760E-02 |
Normal-vs-Extreme_Obese |
8.059500E-03 |
Normal_Weight-vs-Extreme_Weight |
2.567400E-01 |
Normal_Weight-vs-Obese |
5.337200E-01 |
Normal_Weight-vs-Extreme_Obese |
8.198600E-01 |
Extreme_Weight-vs-Obese |
1.461580E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.872200E-01 |
Obese-vs-Extreme_Obese |
4.800600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.666400E-01 |
Normal-vs-Age(41-60Yrs) |
3.241800E-03 |
Normal-vs-Age(61-80Yrs) |
4.541899999988E-06 |
Normal-vs-Age(81-100Yrs) |
2.118300E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.538400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.396400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.624200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.675400E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.602600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.673400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.41960000000519E-05 |
Normal-VS-Type2 PRCC |
1.697600E-03 |
Normal-VS-KIRP CIMP |
2.373600E-02 |
Normal-VS-Unclassified PRCC |
1.616420E-01 |
Type1 PRCC-VS-Type2 PRCC |
3.001200E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.780000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.016200E-02 |
Type2 PRCC-VS-KIRP CIMP |
8.644200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.591200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.250800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.358620E-04 |
Normal-vs-N1 |
4.214000E-04 |
Normal-vs-N2 |
3.521500E-03 |
N0-vs-N1 |
8.217200E-01 |
N0-vs-N2 |
2.266400E-01 |
N1-vs-N2 |
2.426800E-01 |
|
|